Lv42
518 积分 2025-10-14 加入
Abstract 9318: The Safety, Pharmacokinetics, Pharmacodynamics and Immunogenicity of Ebronucimab in Healthy Volunteers: Result From a Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Dose-Escalation Study
20小时前
求助中
TAFOLECIMAB IN CHINESE PATIENTS WITH DIABETES MELLITUS: A POOLED ANALYSIS OF EFFICACY AND SAFETY DATA FROM PHASE 3 RANDOMIZED, PLACEBO-CONTROLLED TRIALS
20小时前
求助中
A Phase I Study to Evaluate the Relative Bioavailability, Pharmacodynamics, and Safety of a Single Subcutaneous Injection of Recaticimab at Three Different Sites in Healthy Chinese Subjects
21小时前
已完结
Recaticimab as Add-On Therapy to Statins for Nonfamilial Hypercholesterolemia
21小时前
已完结
Efficacy and safety of Ebronucimab, in patients with primary hypercholesterolemia and mixed hyperlipidemia: Results from a randomized, double-blind, placebo-controlled phase III clinical study
21小时前
已完结
皖公网安备34019202002308
